rs34970181

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_ModerateBP6_Very_StrongBS1

The NM_001203.3(BMPR1B):​c.1112G>A​(p.Arg371Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000933 in 1,613,874 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R371L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00086 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00094 ( 1 hom. )

Consequence

BMPR1B
NM_001203.3 missense

Scores

4
9
6

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts U:1B:2O:1

Conservation

PhyloP100: 8.00

Publications

14 publications found
Variant links:
Genes affected
BMPR1B (HGNC:1077): (bone morphogenetic protein receptor type 1B) This gene encodes a member of the bone morphogenetic protein (BMP) receptor family of transmembrane serine/threonine kinases. The ligands of this receptor are BMPs, which are members of the TGF-beta superfamily. BMPs are involved in endochondral bone formation and embryogenesis. These proteins transduce their signals through the formation of heteromeric complexes of 2 different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Type II receptors bind ligands in the absence of type I receptors, but they require their respective type I receptors for signaling, whereas type I receptors require their respective type II receptors for ligand binding. Mutations in this gene have been associated with primary pulmonary hypertension. Several transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Feb 2012]
BMPR1B Gene-Disease associations (from GenCC):
  • brachydactyly type A2
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
  • acromesomelic dysplasia 3
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • brachydactyly
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • brachydactyly type A1D
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • brachydactyly type A1
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • acromesomelic dysplasia 2A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • acromesomelic dysplasia 2B
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • pulmonary arterial hypertension
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.13577956).
BP6
Variant 4-95148783-G-A is Benign according to our data. Variant chr4-95148783-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 441001.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000861 (131/152138) while in subpopulation SAS AF = 0.00187 (9/4816). AF 95% confidence interval is 0.000975. There are 0 homozygotes in GnomAd4. There are 69 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BMPR1BNM_001203.3 linkc.1112G>A p.Arg371Gln missense_variant Exon 11 of 13 ENST00000515059.6 NP_001194.1 O00238-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BMPR1BENST00000515059.6 linkc.1112G>A p.Arg371Gln missense_variant Exon 11 of 13 1 NM_001203.3 ENSP00000426617.1 O00238-1

Frequencies

GnomAD3 genomes
AF:
0.000862
AC:
131
AN:
152020
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000676
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000459
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.00187
Gnomad FIN
AF:
0.000472
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00116
Gnomad OTH
AF:
0.000480
GnomAD2 exomes
AF:
0.000994
AC:
250
AN:
251396
AF XY:
0.000935
show subpopulations
Gnomad AFR exome
AF:
0.000677
Gnomad AMR exome
AF:
0.000955
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000544
Gnomad FIN exome
AF:
0.000554
Gnomad NFE exome
AF:
0.00120
Gnomad OTH exome
AF:
0.000978
GnomAD4 exome
AF:
0.000941
AC:
1375
AN:
1461736
Hom.:
1
Cov.:
31
AF XY:
0.000898
AC XY:
653
AN XY:
727166
show subpopulations
African (AFR)
AF:
0.000657
AC:
22
AN:
33468
American (AMR)
AF:
0.000827
AC:
37
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26128
East Asian (EAS)
AF:
0.000428
AC:
17
AN:
39696
South Asian (SAS)
AF:
0.00145
AC:
125
AN:
86254
European-Finnish (FIN)
AF:
0.000431
AC:
23
AN:
53420
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5766
European-Non Finnish (NFE)
AF:
0.000986
AC:
1096
AN:
1111904
Other (OTH)
AF:
0.000878
AC:
53
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
82
165
247
330
412
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000861
AC:
131
AN:
152138
Hom.:
0
Cov.:
32
AF XY:
0.000928
AC XY:
69
AN XY:
74386
show subpopulations
African (AFR)
AF:
0.000674
AC:
28
AN:
41514
American (AMR)
AF:
0.000459
AC:
7
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.000387
AC:
2
AN:
5170
South Asian (SAS)
AF:
0.00187
AC:
9
AN:
4816
European-Finnish (FIN)
AF:
0.000472
AC:
5
AN:
10584
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00116
AC:
79
AN:
68010
Other (OTH)
AF:
0.000475
AC:
1
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
6
12
19
25
31
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00100
Hom.:
0
Bravo
AF:
0.000808
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.000581
AC:
5
ExAC
AF:
0.00110
AC:
133
EpiCase
AF:
0.000873
EpiControl
AF:
0.000771

ClinVar

Significance: Likely benign
Submissions summary: Uncertain:1Benign:2Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

BMPR1B-related disorder Uncertain:1
May 28, 2024
PreventionGenetics, part of Exact Sciences
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

The BMPR1B c.1112G>A variant is predicted to result in the amino acid substitution p.Arg371Gln. This variant was reported in an individual with pulmonary arterial hypertension (Supplementary Dataset 1 in Wang et al. 2018. PubMed ID: 30578397) and in a patient with cleft lip with/without cleft palate (Marini et al. 2019. PubMed ID: 31063268). This variant is reported in 0.13% of alleles in individuals of South Asian descent in gnomAD, including one homozygous individual. This variant has been interpreted by a single submitter in ClinVar as likely benign (https://preview.ncbi.nlm.nih.gov/clinvar/variation/441001/). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Type A2 brachydactyly;C4225404:Acromesomelic dysplasia 3 Benign:1
Dec 16, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Type A2 brachydactyly Other:1
-
GenomeConnect, ClinGen
Significance:not provided
Review Status:no classification provided
Collection Method:phenotyping only

GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.89
BayesDel_addAF
Benign
-0.16
T
BayesDel_noAF
Uncertain
-0.040
CADD
Pathogenic
32
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.79
D;D;.;D;D
Eigen
Uncertain
0.54
Eigen_PC
Uncertain
0.53
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.97
.;.;D;.;D
M_CAP
Benign
0.049
D
MetaRNN
Benign
0.14
T;T;T;T;T
MetaSVM
Benign
-0.49
T
MutationAssessor
Benign
-0.070
N;N;.;N;N
PhyloP100
8.0
PrimateAI
Pathogenic
0.87
D
PROVEAN
Uncertain
-3.9
D;D;D;D;D
REVEL
Uncertain
0.33
Sift
Uncertain
0.0010
D;D;D;D;D
Sift4G
Uncertain
0.0020
D;D;D;D;D
Polyphen
1.0
D;D;.;D;D
Vest4
0.81
MVP
0.75
MPC
0.21
ClinPred
0.043
T
GERP RS
5.5
Varity_R
0.84
gMVP
0.85
Mutation Taster
=69/31
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34970181; hg19: chr4-96069934; COSMIC: COSV52779885; API